Abstract:Cisplatin (CisPt) is an anticancer agent that has been used for decades to treat a variety of cancers. CisPt treatment causes many side effects due to interactions with proteins that detoxify the drug before reaching the DNA. One key player in CisPt resistance is the cellular copper-transport system involving the uptake protein Ctr1, the cytoplasmic chaperone Atox1 and the secretory path ATP7A/B proteins. CisPt has been shown to bind to ATP7B, resulting in vesicle sequestering of the drug. In addition, we and others showed that the apo-form of Atox1 could interact with CisPt in vitro and in vivo. Since the function of Atox1 is to transport copper (Cu) ions, it is important to assess how CisPt binding depends on Cu-loading of Atox1. Surprisingly, we recently found that CisPt interacted with Cu-loaded Atox1 in vitro at a position near the Cu site such that unique spectroscopic features appeared. Here, we identify the binding site for CisPt in the Cu-loaded form of Atox1 using strategic variants and a combination of spectroscopic and chromatographic methods. We directly prove that both metals can bind simultaneously and that the unique spectroscopic signals originate from an Atox1 monomer species. Both Cys in the Cu-site (Cys12, Cys15) are needed to form the di-metal complex, but not Cys41. Removing Met10 in the conserved metal-binding motif makes the loop more floppy and, despite metal binding, there are no metal-metal electronic transitions. In silico geometry minimizations provide an energetically favorable model of a tentative ternary Cu-Pt-Atox1 complex. Finally, we demonstrate that Atox1 can deliver CisPt to the fourth metal binding domain 4 of ATP7B (WD4), indicative of a possible drug detoxification mechanism.

The Anticancer Drug Cisplatin Can Cross-Link the Interdomain Zinc Site on Human Albumin.

Inhibitory Effect of Cisplatin on Proteasome

Crystallographic Analysis of Interaction Between Cisplatin and Human Serum Albumin: Effect of Fatty Acid

Mass Spectrometry Evidence for Cisplatin As a Protein Cross-Linking Reagent.

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Systematic Identification of Proteins Binding with Cisplatin in Blood by Affinity Chromatography and a Four-Dimensional Proteomic Method.

A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein

Discovery Of Cisplatin Binding To Thymine And Cytosine On A Single-Stranded Oligodeoxynucleotide By High Resolution Ft-Icr Mass Spectrometry

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1

Cisplatin reacts with the RING finger domain of RNF11 and interferes with the protein functions

Study on the Interactions Between Cisplatin and Cadherin by Fluorescence Spectrometry and Atomic Force Microscopy.

Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking

Identification Of Binding Sites Of Cisplatin To Human Copper Chaperone Protein Cox17 By High-Resolution Ft-Icr-Ms

Berplatin: A Conjugate of Berberine and Cisplatin Serving As a Potent Antitumor Agent with Distinctive Tumor Cell Uptake and Minimal Side Effects

Discovery of cisplatin-binding proteins by competitive cysteinome profiling

The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation.

Pt(IV) Prodrugs Containing Microtubule Inhibitors Displayed Potent Antitumor Activity and Ability to Overcome Cisplatin Resistance.

Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution

Noncovalent Interactions Between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin.

Cisplatin Protects Against Acute Liver Failure By Inhibiting Nuclear Hmgb1 Release

The Formation of Intracellular Nanoparticles Correlates with Cisplatin Resistance